The Central Vaccine Research Institute, domestic first approval for goat contagious agalactia vaccine

[Livestock News Reporter Kim Young-gil] 'Caprishot Caseous Lymphadenitis' vaccine expected to be released in the first half of next year Contains both bacterial bodies and toxoid 'Excellent immunogenicity, improved productivity' The Central Vaccine Research Institute (Representative Yoon In-jung) received approval for the animal pharmaceutical item from the Animal and Plant Quarantine Agency on June 25 for the prevention vaccine for goat caseous lymphadenitis (Caseous Lymphadenitis, CLA), 'Caprishot Caseous Lymphadenitis'.

[Livestock News Reporter Kim Young-gil] ‘Caprishot Caseous Lymphadenitis’ Scheduled for Release in First Half of Next Year Contains Both Bacterin and Toxoid ‘Excellent Immunogenicity, Productivity Enhancement’ The Central Vaccine Research Institute (Representative Yoon In-joong) received approval for the veterinary pharmaceutical product item for the goat caseous lymphadenitis (Caseous Lymphadenitis, CLA) preventive vaccine ‘Caprishot Caseous Lymphadenitis’ from the Animal and Plant Quarantine Agency on June 25 last year. This is the first domestic approval for a goat caseous lymphadenitis item. It is scheduled to be released in the first half of next year. Goat caseous lymphadenitis is a chronic bacterial disease caused by infection with Corynebacterium pseudotuberculosis. If infected, abscesses form in the lymph nodes and organs of the animal, leading to decreased weight gain and a sharp drop in meat and milk production. It is estimated that a farm that ships 100 goats annually ...